Animal models in the genomic era: Possibilities and limitations with special emphasis on schizophrenia

Behavioural Pharmacology

Volumn 14, Issue 5-6, 2003, Pages 409-417

  Ellenbroek, Bart A ^a  

^a Dept of Psychoneuropharmacology ^*  (Netherlands)

Author keywords

Animal models; Environmental models; Gene environment interaction; Genetic model; Schizophrenia

Indexed keywords

ANIMAL MODEL; BIOMEDICINE; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; GENETIC MODEL; HEREDITY; MOLECULAR GENETICS; NONHUMAN; SCHIZOPHRENIA;

ANIMALS; DISEASE MODELS, ANIMAL; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; MODELS, GENETIC; SCHIZOPHRENIA;

EID: 0141757315     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (110)

1. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R (1982). Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17:649-654.
2. Adler LE, Rose GM, Freedman R (1986). Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine and haloperidol. Biol Psychiatry 21:787-798.
3. Agid O, Shapira B, Zislin J, Ritsner M, Hanin B, Murad H, et al. (1999). Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Mol Psychiatry 4:163-172.
4. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE (2003). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325:1212-1213.
5. Ballard TM, Pauly EM, Higgins GA, Ouagazzal AM, Mutel V, Borroni E, et al. (2002). Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity. J Neurosci 22:6713-6723.
6. Barbeau D, Liang JJ, Robitalille Y, Quirion R, Srivastava LK (1995). Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci USA 92:2785-2789.
7. Baruch I, Hemsley DR, Gray JA (1988). Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis 176:598-606.
8. Bassett AS, Chow EWC, Brzustowicz L (2001). The genetics of schizophrenia. Neurosci News 4:20-26.
9. Beal MF (1994). Neurochemistry and toxin models in Huntington's disease. Curr Opin Neurol 7:542-547.
10. Becker A, Schroeder H, Mann T, Huether G, Grecksch G (2002). Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia. Int J Neuropsychopharmacol 5:S61.
11. 2 induced panic attacks. Am J Psychiatry 155:1184-1188.
12. Black MD, Selk DE, Hitchcock JM, Wettstein JG, Sorensen SM (1999). On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia. Neuropharmacology 38:1299-1306.
13. Borlongan CV, Koutouzis TK, Randall TS, Freeman TB, Cahill DW, Sanberg PR (1995). Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats. Brain Res Bull 36:549-556.
14. Borrell J, Vela JM, Arevalo MA, Molina HE, Guaza C (2002). Prenatal immune challenge disrupts sensorimotor gating in adult rats: Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26:204-215.
15. Boutros NN, Bonnet KA, Millana R, Liu J (1997). A parametric study of the N40 auditory evoked response in rats. Biol Psychiatry 42:1051-1059.
16. Braff D, Stone C, Callaway E, Geyer MA, Glick ID, Bali L (1978). Prestimulus effects of human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343.
17. Bramon E, Kelly J, van Os J, Murray RM (2001). The cascade of increasingly deviant development that culminates in the onset of schizophrenia. Neurosci News 4:5-19.
18. Brouillet E, Conde F, Beal MF, Hantraye P (1999). Replicating Huntington's disease phenotype in experimental animals. Prog Neurobiol 59:427-468.
19. Brown AS, van Os J, Driessens C, Hoek HW, Susser ES (2000). Further evidence of relation between prenatal famine and major affective disorder. Am J Psychiatry 157:190-195.
20. Carlsson A (1988). The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179-186.
21. Conti LH, Palmer AA, Vanella JJ, Printz MP (2001). Latent inhibition and conditioning in rat strains which show differential prepulse inhibition. Behav Genet 31:325-333.
22. Cools AR, Brachten R, Heeren D, Willemen A, Ellenbroek B (1990). Search after neurobiological profile of individual-specific features of Wistar rats. Brain Res Bull 24:49-69.
23. de Beurs E, Beekman A, Geerlings S, Deeg D, Van Dyck R, Van Tilburg W (2001). On becoming depressed or anxious in late life: similar vulnerability factors but different effects of stressful life events. Br J Psychiatry 179:426-431.
24. de Bruin NMWJ, Ellenbroek BA, van Luijtelaar ELJM, Cools AR, Stevens KE (2001). Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell. Neuroscience 105:169-180.
25. DeLisi LE, Shaw SH, Crow TJ, Shields G, Smith AB, Larach VW, et al. (2002). A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am J Psychiatry 159:803-812.
26. Diaz R, Fuxe K, Ogren SO (1997). Prenatal corticosterone treatment induces long-term changes in spontaneous and apomorphine-mediated motor activity in male and female rats. Neuroscience 81:129-140.
27. Dirks A (2001). Corticotropin-releasing Hormone, Stress and Anxiety. Physiological, Neuroendocrine and Behavioural Studies. Nieuwegein: Budde Elinkwijk.
28. Ellenbroek BA, Cools AR (1995). Maternal separation reduces latent inhibition in the conditioned taste aversion paradigm. Neurosci Res Comm 17:27-33.
29. Ellenbroek BA, Cools AR (1998). The neurodevelopmental hypothesis of schizophrenia: Clinical evidence and animal models. Neurosci Res Comm 22:127-136.
30. Ellenbroek BA, Cools AR (2000a). Animal models for schizophrenia: An introduction. In: Ellenbroek BA, Cools AR (editors): Atypical Antipsychotics. Basel: Birkhauser Verlag; pp. 35-53.
31. Ellenbroek BA, Cools AR (2000b). Animal models for the negative symptoms of schizophrenia. Behav Pharmacol 11:223-233.
32. Ellenbroek BA, Cools AR (2000c). The long-term effects of maternal deprivation depend on the genetic background. Neuropsychopharmacology 23:99-106.
33. Ellenbroek BA, Cools AR (2002a.) Animal models for schizophrenia. In: D'Haenen H, den Boer JA, Westenberg H, Willner P (editors): Textbook of Biological Psychiatry. Chichester: John Wiley & Sons; pp. 567-580.
34. Ellenbroek BA, Cools AR (2002b). Apomorphine susceptibility and animal models for psychopathology: Genes and environment. Behav Genet 32:349-361.
35. Ellenbroek BA, Cools AR (2002c). Early maternal deprivation and prepulse inhibition - the role of the postdeprivation environment. Pharmacol Biochem Behav 73:177-184.
36. Ellenbroek BA, Knobbout DK, Cools AR (1997). The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured the conditioned taste-aversion paradigm. Psychopharmacology 129:112-120.
37. Ellenbroek BA, van Luytelaar EG, Frenken M, Cools AR (1999). Sensory gating in rats: Lack of correlation between auditory evoked potential gating and prepulse inhibition. Schizophr Bull 25:777-788.
38. Ellenbroek BA, Sluyter F, Cools AR (2000). The role of genetic and early environmental factors in determining apomorphine susceptibility. Psychopharmacology 148:124-131.
39. Ellenbroek BA, van den Kroonenberg PTJM, Cools AR (1998). The effects of an early stressful life event on sensorimotor gating in adult rats. Schizophr Res 30:251-260.
40. Feldon J, Weiner I (1992). From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. J Psychiatr Res 26:345-366.
41. Flores G, Wood GK, Barbeau D, Quirion R, Srivastava LK (1998). Lewis and Fischer rats: a comparison of dopamine transporter and receptors levels. Brain Res 814:34-40.
42. Gainetdinov RR, Jones SR, Fumagalli F, Wightman RM, Caron MG (1998). Reevaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Res Brain Res Rev 26:148-153.
43. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999). Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401.
44. Gainetdinov RR, Mohn AR, Caron MG (2001). Genetic animal models: focus on schizophrenia. Trends Neurosci 24:527-533.
45. Geyer MA, Braff DL (1987). Startle habituation and sensorimotor gating in schizophrenia and related animal models. SchizophrBull 13:643-668.
46. Geyer MA, Wilkinson LS, Humby T, Robbins TW (1993). Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol Psychiatry 34:361-372.
47. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
48. Gottesman II, Shields J (1982.) Schizophrenia: The Epigenetic Puzzle. Cambridge: Cambridge University Press.
49. Graham F (1975). The more or less startling effects of weak prepulses. Psychophysiology 12:238-248.
50. Gray NS, Pilowsky LS, Gray JA, Kerwin RW (1995). Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophr Res 17:95-107.
51. Grecksch G, Bernstein HG, Becker A, Hollt V, Bogerts B (1999). Disruption of latent inhibition in rats with postnatal hippocampal lesions. Neuropsychopharmacology 20:525-532.
52. Hall W, Degenhardt L (2000). Cannabis use and psychosis: a review of clinical and epidemiological evidence. Aust N Z J Psychiatry 34:26-34.
53. Hambrecht M, Hafner H (2000). Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Aust N Z J Psychiatry 34:468-475.
54. Harris HW, Nestler EJ (1996). Immunohistochemical studies of mesolimbic dopaminergic neurons in Fischer 344 and Lewis rats. Brain Res 706:1-12.
55. Husum H, Termeer E, Mathe AA, Bolwig TG, Ellenbroek BA (2002). Early maternal deprivation alters hippocampal levels of neuropeptide Y and calcitonin-gene-related peptide in adult rats. Neuropharmacology 42:798-806.
56. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG (1998). Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 95:4029-4034.
57. Judd LL, McAdams L, Budnick B, Braff DL (1992). Sensory gating deficits in schizophrenia: new results. Am J Psychiatry 149:488-493.
58. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ (1992). Childhood parental loss and adult psychopathology in women. A twin study perspective. Arch Gen Psychiatry 49:109-116.
59. Kendler KS, Pedersen N, Johnson L, Neale MC, Mathe AA (1993). A pilot Swedish twin study of affective illness, including hospital- and population-ascertained subsamples. Arch Gen Psychiatry 50:699-700.
60. Kendler KS, Karkowski LM, Neale MC, Prescott CA (2000). Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 57:261-269.
61. Kew JNC, Koester A, Moreau JL, Jenck F, Ouagazzal AM, Mutel V, et al. (2000). Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site. J Neurosci 20:4037-4049.
62. Killcross AS, Dickinson A, Robbins TW (1994). Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: Implications for animal models of schizophrenic attentional dysfunction. Psychopharmacology 115:185-195.
63. Knobler HY, Dycian A, Katz G, Intrator O, Abramowitz MZ, Lerner Y, Kron S (2000). First psychotic episodes among Israeli youth during military service. Mil Med 165:169-172.
64. Koenig JI, Kirkpatrick B, Lee P (2002). Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 27:309-318.
65. Kornhuber HH (1983). Chemistry, physiology and neuropsychology of schizophrenia: Towards an earlier diagnosis of schizophrenia. Arch Psychiatr Nervenkr 233:415-422.
66. Kumari V, Soni W, Mathew VM, Sharma T (2000). Prepulse inhibition of the startle response in men with schizophrenia - Effects of age of onset of illness, symptoms, and medication. Arch Gen Psychiatry 57:609-614.
67. Levine S (1994). The ontogeny of the hypothalamic-pituitary-adrenal axis. The influence of maternal factors. Ann N Y Acad Sci 746:275-288.
68. Lipska BK, Weinberger DR (1995). Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proc Natl Acad Sci USA 92:8906-8910.
69. Lipska BK, Jaskiw GE, Weinberger DR (1993). Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 9:67-75.
70. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR (1995). Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) 122:35-43.
71. Lubow RE (1989). Latent Inhibition and Conditoned Attention Theory. New York: Cambridge University Press.
72. Miyamoto Y, Yamada K, Noda Y, Mori H, Mishina M, Nabeshima T (2001). Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon 1 subunit. J Neurosci 21:750-757.
73. Miyazato H, Skinner RD, Reese NB, Mukawa J, Garcia RE (1996). Midlatency auditory evoked potentials and the startle response in the rat. Neuroscience 75:289-300.
74. Mocsary Z, Bradberry CW (1996). Effect of ethanol on extracellular dopamine in nucleus accumbens: comparison between Lewis and Fischer 344 rat strains. Brain Res 706:194-198.
75. Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999). Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436.
76. Moser PC, Hitchcock JM, Lister S, Moran PM (2000). The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res Brain Res Rev 33:375-307.
77. Nagamoto HT, Adler LE, Waldo MC, Freedman R (1989). Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biol Psychiatry 25:549-561.
78. Oitzl MS, van Haarst AD, Sutanto W, de Kloet ER (1995). Corticosterone, brain mineralocorticoid receptors (MRs) and the activity of the hypothalamic-pituitary-adrenal axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology 20:655-675.
79. Palmer AA, Dulawa SC, Mottiwala AA, Conti LH, Geyer MA, Printz MP (2000). Prepulse startle deficit in the brown Norway rat: A potential genetic model. Behav Neurosci 114:374-388.
80. Parwani A, Duncan EJ, Bartlett E, Madonick SH, Efferen TR, Rajah R, et al. (2000). Impaired prepulse inhibition of acoustic startle in schizophrenia. Biol Psychiatry 47:662-669.
81. Ralph RJ, Paulus MP, Fumagalli F, Caron MG, Geyer MA (2001). Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: Differential effects of D1 and D2 receptor antagonists. J Neurosci 21:305-313.
82. Rojo-Moreno L, Livianos-Aldana L, Cervera-Martinez G, Dominguez-Carabantes JA, Reig-Cebrian MJ (2002). The role of stress in the onset of depressive disorders A controlled study in a Spanish clinical sample. Soc Psychiatry Psychiatr Epidemiol 37:592-598.
83. Rueter MA, Scaramella L, Wallace LE, Conger RD (1999). First onset of depressive or anxiety disorders predicted by the longitudinal course of internalizing symptoms and parent-adolescent disagreements. Arch Gen Psychiatry 56:726-732.
84. Schellenberg GD (1995). Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc Natl Acad Sci USA 92:8552-8559.
85. Schneider M, Koch M (2003). Chronic pubertal, but not adult chronic cannabinoid treatment inpairs sensorimotor gating, recognition memory and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology (in press).
86. Schwarzkopf SB, Lamberti JS, Smith DA (1993). Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition. Biol Psychiatry 33:815-828.
87. Solomon PR, Staton DM (1982). Differential effects of microinjections of D-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biol Psychiatry 17:743-756.
88. Sontag TA, Ellenbroek BA, Cools AR (2003). Removal of short-term isolation stress differentially influences prepulse inhibition in Apo-Sus and Apo-Unsus rats. Behav Brain Res 14:17-175.
89. Spielewoy C, Roubert C, Hamon M, Nosten BM, Betancur C, Giros B (2000). Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav Pharmacol 11:279-290.
90. Stephens DN, Mead AN, Ripley TL (2002). Studying the neurobiology of stimulant and alcohol abuse and dependence in genetically manipulated mice. Behav Pharmacol 13:327-345.
91. Stevens KE, Fuller LL, Rose GM (1991). Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating. Brain Res 555:91-98.
92. Stevens KE, Johnson RG, Rose GM (1997). Rats reared in social isolation show schizophrenia-like changes in auditory gating. Pharmacol Biochem Behav 58:1031-1036.
93. Stohr T, Szuran T, Welzl H, Pliska V, Feldon J, Pryce C (2000). Lewis/Fischer strain differences in endocrine and behavioural responses to environmental challenge. Pharmacol Biochem Behav 67:809-819.
94. Susser ES, Lin SP (1992). Schizophrenia after prenatal exposure to the Dutch hunger winter of 1944-1945. Arch Gen Psychiatry 49:983-988.
95. Swerdlow NR, Braff DL, Hartston H, Perry W, Geyer MA (1996). Latent inhibition in schizophrenia. Schizophr Res 20:91-103.
96. Takeuchi T, Kiyama Y, Nakamura K, Tsujita M, Matsuda I, Mori H, et al. (2001). Roles of the glutamate receptor epsilon 2 and delta 2 subunits in the potentiation and prepulse inhibition of the acoustic startle reflex. Eur J Neurosci 14:153-160.
97. The Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable in Huntington's disease chromosome. Cell 72:983.
98. Tobin AJ, Signer ER (2002). Huntington's disease, the challenge for cell biologists. Trends Cell Biol 10:531-536.
99. Tomasiewicz H, Ono K, Yee D, Thompson C, Goridis C, Rutishauser U, Magnuson T (1993). Genetic deletion of a neural cell adhesion molecule variant (N-CAM-180) produces distinct defects in the central nervous system. Neuron 11:1163-1174.
100. van Os J, Jones P, Sham P, Bebbington P, Murray RM (1998). Risk factors for onset and persistence of psychosis. Soc Psychiatry Psychiatr Epidemiol 33:596-605.
101. Varty GB, Geyer MA (1998). Effects of isolation rearing on startle reactivity, habituation, and prepulse inhibition in male Lewis, Sprague-Dawley, and Fischer F344 rats. Behav Neurosci 112:1450-1457.
102. Walker EF, Diforio D (1997). Schizophrenia: A neural diathesis-stress model. Psychol Rev 104:667-685.
103. Walker EF, Walder DJ, Reynolds F (2001). Developmental changes in cortisol secretion in normal and at-risk youth. Dev Psychobiol 13:721-732.
104. Weiner I, Lubow RE, Feldon J (1988). Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav 30:871-878.
105. Wilkinson LS, Killcross SS, Humby T, Hall FS, Geyer MA, Robbins TW (1994). Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition. Neuropsychopharmacology 10:61-72.
106. Williams JH, Wellman NA, Geaney DP, Cowen PJ, Feldon J, Rawlins JN (1998). Reduced latent inhibition in people with schizophrenia: an effect of psychosis or its treatment. Br J Psychiatry 172:243-249.
107. Williams RA, Hagerty BM, Yousha SM, Hoyle KS, Oe H (2002). Factors associated with depression in navy recruits. J Clin Psychol 58:323-337.
108. Wolterink G, Daenen EWPM, Van Ree JM (2000). Animal models for schizophrenia. Neurosci Res Comm 27:143-154.
109. Wood GK, Lipska BK, Weinberger DR (1997). Behavioral changes in rats with early ventral hippocampal damage vary with age at damage. Brain Res Dev Brain Res 101:17-25.
110. Wood GK, Tomasiewicz H, Rutishauser U, Magnuson T, Quirion R, Rochford J, Srivastava LK (1998). NCAM-180 knockout mice display increased lateral ventricular size and reduced prepulse inhibition of startle. Neuroreport 9:461-466.